Circulating endothelin and nitrate-nitrite relate to hemodynamic and metabolic variables in human septic shock

Shock

Volumn 11, Issue 3, 1999, Pages 160-166

  Groeneveld, A B Johan ^a,b   Hartemink, Koen J ^a   De Groot, Marcel C M ^a   Visser, Jelle ^a   Thijs, Lambertus G ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTONIC AGENT; CREATININE; CYTOKINE; DOPAMINE; ENDOTHELIN; NITRATE; NITRIC OXIDE; NITRITE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD; BLOOD VESSEL; CLINICAL TRIAL; FEMALE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; MALE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; SEPTIC SHOCK; ULTRASTRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSELS; CARDIOTONIC AGENTS; CREATININE; CYTOKINES; DOPAMINE; ENDOTHELINS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; NOREPINEPHRINE; PROSPECTIVE STUDIES; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 0033087818     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199903000-00002     Document Type: Article

References (45)

1. Groeneveld ABJ, Bronsveld W, Thijs LG: Hemodynamic determinants of mortality in human septic shock. Surgery 99:140-152, 1986.
2. Groeneveld ABJ, Bronsveld W, Kester A, Thijs LG: Relation of arterial blood lactate to oxygen delivery and hemodynamic variables in human shock states. Circ Shock 22:35-53, 1987.
3. Curzen NP, Griffiths MJD, Evans TW: Role of the endothelium in modulating the vascular response to sepsis. Clin Sci 86:359-374, 1994.
4. Hayes MA, Timmins AC, Yau EHS, Palazzo M, Watson D, Hinds CJ: Oxygen transport patterns in patients with sepsis syndrome or septic shock: Influence of treatment and relationship to outcome. Crit Care Med 25:926-936, 1997.
5. Schneider F, Lutun Ph, Couchopt A, Bilbault P, Tempé JD: Plasma cyclic guanosine 3′-5′ monophosphate concentrations and low vascular resis-tance in human septic shock. Intensive Care Med 19:99-104, 1993.
6. Kilbourn RG, Szabo C, Traber DL: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: Lessons learned from experimental and clinical studies. Shock 7:235-246, 1997.
7. Li T, Croce K, Winquist RJ: Regional differences in the effects of septic shock on vascular reactivity in the rabbit. J Pharmacol Exp Ther 261: 959-962, 1992.
8. Voerman HJ, Stehouwer CDA, Van Kamp GJ, Strack van Schijndel RJM, Groeneveld ABJ, Thijs LG: Plasma endothelin levels are increased during septic shock. Crit Care Med 20:1097-1101, 1992.
9. Mulder MF, Van Lambalgen AA, Huisman E, Visser JJ, Van den Bos GC, Thijs LG: Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol 266:H1558-H1564, 1994.
10. Paya D, Maupoil V, Schott C, Rochette L, Stoclet J-C: Temporal relationships between levels of circulating NO derivates, vascular NO production and hyporeactivity to noradrenaline induced by endotoxin in rats. Cardiovasc Res 30:952-959, 1995.
11. Battistini B, Forget M-A, Laight D: Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines. Shock 5:167-183, 1996.
12. Hollenberg SM, Piotrowski MJ, Parrillo JE: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. Am J Physiol 272:R969-R974, 1997.
13. Ikeda U, Yamamoto K, Maeda Y, Shimpo M, Kanbe T, Shimada K: Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 29:65-69, 1997.
14. Sharma AC, Motew SJ, Farias S, Alden KJ, Bosmann HB, Law WR, Ferguson JL: Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Moll Cell Cardiol 29:1469-1477, 1997.
15. B receptors on the liver dysfunction and injury by endotoxaemia in the rat. Br J Pharmacol 119:479-486, 1996.
16. Curzen NP, Kaddoura S, Griffiths MJD, Evans TW: Endothelin-1 in rat endotoxemia: mRNA expression and vasoreactivity in pulmonary and systemic circulations. Am J Physiol 272:H2353-H2360, 1997.
17. Wanecek M, Oldner A, Rudehill A, Sollevi A, Alving K, Weitzberg E: Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan. Shock 7:364-370, 1997.
18. Yamamoto S, Burman HP, O, Donnell CP, Cahill PA, Robotham JL: Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock. Am J Physiol 272:H1239-H1249, 1997.
19. 2 extraction capabilities during endotoxic shock. J Appl Physiol 83;1164-1173, 1997.
20. Alden KJ, Motew SJ, Sharma AC, Ferguson JL: Effect of aminoguanidine on plasma nitric oxide by-products and blood flow during chronic peritoneal sepsis. Shock 9:289-295, 1998.
21. Forfia PR, Zhang X, Ochoa F, et al: Relationship between plasma NOx and cardiac and vascular dysfunction after LPS injection in anesthetized dogs. Am J Physiol 274:H193-H201, 1998.
22. Kruse-Elliott KT, Whorton AR, Olson NC: Role of lipid-derived mediators in tumor necrosis factor-induced endothelin-1 release in vivo. Shock 9:4-45, 1998.
23. Minghini A, Britt LD, Hill MA: Interleukin-1 and interleukin-6 mediated skeletal muscle arteriolar vasodilation: In vitro versus in vivo studies. Shock 9:210-215, 1998.
24. Wray GM, Millar CG, Hinds CJ, Thiemermann C: Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock 9:329-335, 1998.
25. Ochoa JB, Udekwu AO, Billiar TR, et al: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214:621-626, 1991.
26. Evans T, Carpenter A, Kinderman H, Cohen J: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41:77-81, 1993.
27. Barthlen W, Stadler J, Lehn NL, Miethke T, Bartels H, Siewert JR: Serum levels of end products of nitric oxide synthesis correlate positively with tumor necrosis factor a and negatively with body temperature in patients with postoperative abdominal sepsis. Shock 6:398-401, 1994.
28. Tracey WR, Tse J, Carter G: Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Therap 272:1011-1015, 1995.
29. Wong HR, Carcillo JA, Burckart G, Shah N, Janosky JE: Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. Crit Care Med 23:835-842, 1995.
30. Zeballos GA, Bernstein RD, Thompson CI, et al: Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 91:2982-2988, 1995.
31. Groeneveld PHP, Kwappenberg KMC, Langermans JAM, Nibbering PH, Curtis L: Nitric oxide (NO) production correlates with renal insufficiency and multiple organ dysfunction syndrome in severe sepsis. Intensive Care Med 22:1197-1202, 1996.
32. Groeneveld PHP, Kwappenberg KMC, Langermans JAM, Nibbering PH, Curtis L: Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis. Cytokine 9:138-142, 1997.
33. De Werra I, Jaccard C, Corradin SB, et al: Cytokines, nitrate/nitrite, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607-613, 1997.
34. Rixen D, Siegel JH, Espina NB, Bertolini M: Plasma nitric oxide in posttrauma critical illness: A function of "sepsis" and the physiologic state severity classification quantifying the probability of death. Shock 7:17-28, 1997.
35. Spack L, Havens PL, Griffith OW: Measurements of total plasma nitrite and nitrate in pediatric patients wth the systemic inflammatory response syndrome. Crit Care Med 25:1071-1078, 1997.
36. Doughty LA, Carcillo JA, Kaplan S, Janosky J: Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis. Crit Care Med 26:157-162, 1998.
37. Lüscher TF, Yang Z, Tschudi M, et al.: Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 66:1088-1094, 1990.
38. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH: Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res 75:1086-1095, 1994.
39. Stamler JS, Loh E, Roddy M-A, Currie KE, Creager MA: Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89:2035-2040, 1994.
40. Ahlborg G, Lundberg JM: Nitric oxide-endothelin-1 interactions in humans. J Appl Physiol 82:1593-1600, 1997.
41. Markewitz BA, Michael JR, Kohan DE: Endothelin-1 inhibits the expression of inducible nitric oxide synthase. Am J Physiol 272:L1078-L1083, 1997.
42. Pittet J-F, Morel DR, Hemsen A, et al: Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 213:261-264, 1991.
43. Sanai L, Haynes WG, MacKenzie A, Grant IS, Webb DJ: Endothelin production in sepsis and the adult respiratory distress syndrome. Intens Care Med 22:52-56, 1996.
44. Ohta K, Hirata Y, Shichiri M, et al: Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Intern 39:307-311, 1991.
45. Knaus WA, Draper EA, Wagner D, Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med 13:818-829, 1985.